Maternal Serum CA 125 for aneuploidy detection in early pregnancy |
| |
| Authors: | Mary E. Norton Dr Mitchell S. Golbus |
| |
| Affiliation: | Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143-0720, U.S.A. |
| |
| Abstract: | Maternal serum CA 125 levels were determined at 9–11 menstrual weeks for 26 cases of trisomy 13 (n = 4), trisomy 18 (n = 7), trisomy 21 (n = 15), and appropriate controls. There were no statistically significant differences between groups. |
| |
| Keywords: | Maternal serum CA 125 Fetal aneuploidy Screening |
|
|
